Clinical trial
Coil Assisted Flow Diversion: A Prospective, Single Arm, Multi-center Study to Assess the Safety and Performance of Neqstent in Adjunctive Therapy (CAFI Study)
NCT04187573 is registered in ClinicalTrials.gov with Cerus Endovascular, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Coil Assisted Flow Diversion: A Prospective, Single Arm, Multi-center Study to Assess the Safety and Performance of Neqstent in Adjunctive Therapy (CAFI Study)
- Lead sponsor
- Cerus Endovascular, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 21, 2020
- Completion date
- November 1, 2023
- Enrollment
- 38 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.